Genome stability of programmed stem cell products
Author:
- 1 October 2017
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 120, 108-117
Abstract
No abstract availableKeywords
This publication has 111 references indexed in Scilit:
- BCL-XL Mediates the Strong Selective Advantage of a 20q11.21 Amplification Commonly Found in Human Embryonic Stem Cell CulturesStem Cell Reports, 2013
- Active human retrotransposons: variation and diseaseCurrent Opinion in Genetics & Development, 2012
- Low Incidence of DNA Sequence Variation in Human Induced Pluripotent Stem Cells Generated by Nonintegrating Plasmid ExpressionCell Stem Cell, 2012
- Identification of Aneuploidy-Selective Antiproliferation CompoundsCell, 2011
- Dynamic Changes in the Copy Number of Pluripotency and Cell Proliferation Genes in Human ESCs and iPSCs during Reprogramming and Time in CultureCell Stem Cell, 2011
- Identification of Aneuploidy-Tolerating MutationsCell, 2010
- Mobile Interspersed Repeats Are Major Structural Variants in the Human GenomeCell, 2010
- Physiological Levels of Reactive Oxygen Species Are Required to Maintain Genomic Stability in Stem CellsStem Cells, 2010
- Aurora‐A expressing tumour cells are deficient for homology‐directed DNA double strand‐break repair and sensitive to PARP inhibitionEMBO Molecular Medicine, 2010
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007